The future of pharmacogenetics in the treatment of hypertension.
Cunningham, Patrick N
The future of pharmacogenetics in the treatment of hypertension. [electronic resource] - Pharmacogenomics 02 2019 - 129-132 p. digital
Publication Type: Editorial
1744-8042
10.2217/pgs-2018-0191 doi
Adrenergic beta-Antagonists--adverse effects
Antihypertensive Agents--adverse effects
Blood Pressure--genetics
Calcium Channel Blockers--adverse effects
Humans
Hypertension--drug therapy
Pharmacogenetics--trends
Polymorphism, Single Nucleotide--genetics
The future of pharmacogenetics in the treatment of hypertension. [electronic resource] - Pharmacogenomics 02 2019 - 129-132 p. digital
Publication Type: Editorial
1744-8042
10.2217/pgs-2018-0191 doi
Adrenergic beta-Antagonists--adverse effects
Antihypertensive Agents--adverse effects
Blood Pressure--genetics
Calcium Channel Blockers--adverse effects
Humans
Hypertension--drug therapy
Pharmacogenetics--trends
Polymorphism, Single Nucleotide--genetics